The Genoa CMM program is a pharmacist-led program that evaluates medication therapy for indication, effectiveness, safety and adherence and includes data obtained through pharmacy claims, medical claims and patient reporting.
- This patient-centered initiative is an “opt-in” program. Prior to any notification or request for information going out, the participating member has a conversation with a Genoa clinical pharmacist who will explain the program and obtain consent. Individuals who opt-in agree to release information to their treating providers and back to the health plan. They also agree to engage with the clinical pharmacist and are enrolled for a period of up to 12 months, as clinically indicated.
- Outreach to you. Information shared with you contains information across all of the patient’s health care professionals and supports collaboration on behalf of your patient
- The provider will receive notification via fax. The notification will include a list of current medications, other engaged prescribers, and recommendation(s) related to medications that are being prescribed where there may be an opportunity for therapy optimization. The notification/request has 3 steps:
- Review and respond to recommendations
- Sign and return completed form within 14 days (optional)
- Communicate all prescription changes with the patient and to the patient’s dispensing pharmacy (if applicable)
Genoa’s goal is to be of service to both you and your patient, specifically with regard to medication therapy.
